Search Results
Working Together to Address Health Disparities in the Black Community
Michelle Pastrana, a marketing manager at Baxter and one of the leaders of our Activating Change Today (ACT) racial justice initiative, shares her perspective on how we can work together to address health disparities that impact the Black community.
Baxter Issues Urgent Medical Device Correction to Reinforce Important Safety Information Regarding Possible Risk of Oxygen Desaturation While Using Volara Device in Line With Ventilator in a Home Care Environment
Baxter International Inc. announced today it has issued an Urgent Medical Device Correction for the Volara System (home care) to reinforce important safety information regarding a possible risk of decrease in oxygen levels (oxygen desaturation) or injury that may result in lung tissue damage due to over-expansion (barotrauma) in the home care environment.
Point of Pride with Every Bag
We spoke with Diana, Plant Director of our Haina, Dominican Republic facility, to share perspectives on our employees' connection to our products and her career trajectory. The Haina facility opened in 2012 and today has more than 900 employees. The IV bags made there are distributed globally and used throughout hospitals to help patients.
Supporting Patients in Extraordinary Times
Continuous renal replacement therapy (CRRT) is the cornerstone of treatment in patients with severe acute kidney injury (AKI), one of many complications affecting COVID-19 patients. Throughout the pandemic, Baxter has been doing all it can to help meet the increased need for CRRT products, including filter sets used to remove fluid and uremic toxins from the patient’s blood during CRRT before the cleaned blood is returned to the body.
Baxter Highlights Business Strategies and Innovation at 2022 Investor Conference
Baxter International Inc. (NYSE:BAX), a global medtech leader, will showcase its ongoing trajectory of transformation and growth at its 2022 Investor Conference, being held today in Glenview, Ill. The company's executive leadership team will highlight Baxter’s strategy to continue creating compelling value for patients, clinicians and investors through leading-edge innovation, market expansion, operational efficiency and other vital growth levers.
'In This Job for a Reason'
When a devastating diagnosis left Gabriella and her family searching for answers, her colleagues and own professional experience helped provide a sense of comfort on a loved one’s end-of-life journey
Building Bridges to Elevate Inclusivity
Connecting with Baxter's resource group for Asian employees
Baxter to Host 2022 Investor Conference
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host an investor conference on Wednesday, May 25, 2022 in Glenview, Ill. Chairman and CEO Joe Almeida and other members of Baxter's management team will provide a closer look at the company’s growth strategy, innovation pipeline and longer term financial outlook. The investor conference will feature an innovation hall displaying product and therapy advancements from Baxter's pipeline beginning at 8:00 a.m.
Premixed Medications During Hospital Labor Shortages
In the wake of the COVID-19 pandemic, hospitals around the globe are experiencing significant labor shortages, particularly in the hospital pharmacy and among nursing staff.1,2 With individual healthcare providers managing higher workloads, hospitals are relying more on products like premixed medications that help save time, increase efficiency and support patient safety.
Seeking Answers: Finding Hope
Jake—a teenager with an interest in football and a goal of going to medical school—is forging a new path toward a bright future after a prolonged battle with an illness that was challenging to diagnose and led to some worrying health situations.